Combination Therapy with Ruxolitinib and Hydroxyurea for the Treatment of Myeloid-Predominant Leukocytosis in a Patient with Myelofibrosis

Caocci, Giovanni;La Nasa, Giorgio
2018-01-01

2018
Files in This Item:
File Size Format  
Combination therapy with ruxolitinib and hydroxyurea for the treatment of myeloid-predominant leucocytosis in a patients with myelofibrosis.pdf

Solo gestori archivio

Type: versione editoriale
Size 793.09 kB
Format Adobe PDF
793.09 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie